These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 38361080

  • 1. Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.
    Alsaadi T, Suliman R, Santos V, Al Qaisi I, Carmina P, Aldaher B, Haddad S, Bader Y.
    Neurol Ther; 2024 Apr; 13(2):465-473. PubMed ID: 38361080
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis.
    Messina R, Huessler EM, Puledda F, Haghdoost F, Lebedeva ER, Diener HC.
    Cephalalgia; 2023 Mar; 43(3):3331024231152169. PubMed ID: 36786548
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention.
    Schoenen J, Manise M, Nonis R, Gérard P, Timmermans G.
    Rev Neurol (Paris); 2020 Dec; 176(10):788-803. PubMed ID: 32758365
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study.
    Charleston L, Talon B, Sullivan C, Anderson C, Kymes S, Regnier SA, Soni-Brahmbhatt S, Nahas SJ.
    J Headache Pain; 2023 Aug 02; 24(1):101. PubMed ID: 37532991
    [Abstract] [Full Text] [Related]

  • 13. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ.
    Headache; 2018 Nov 02; 58 Suppl 3():238-275. PubMed ID: 30242830
    [Abstract] [Full Text] [Related]

  • 14. Gepants for Acute and Preventive Migraine Treatment: A Narrative Review.
    Rissardo JP, Caprara ALF.
    Brain Sci; 2022 Nov 24; 12(12):. PubMed ID: 36552072
    [Abstract] [Full Text] [Related]

  • 15. Gepants - a long way to cure: a narrative review.
    Altamura C, Brunelli N, Marcosano M, Fofi L, Vernieri F.
    Neurol Sci; 2022 Sep 24; 43(9):5697-5708. PubMed ID: 35650458
    [Abstract] [Full Text] [Related]

  • 16. Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway.
    Zhou Z, Urman R, Gill K, Park AS, Vuvu F, Patel LB, Lu J, Wade RL, Frerichs L, Bensink ME.
    J Headache Pain; 2023 Nov 09; 24(1):153. PubMed ID: 37946113
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study.
    Jakate A, Blumenfeld AM, Boinpally R, Butler M, Borbridge L, Contreras-De Lama J, McGeeney D, Periclou A, Lipton RB.
    Headache; 2021 Apr 09; 61(4):642-652. PubMed ID: 33818780
    [Abstract] [Full Text] [Related]

  • 18. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Yuan H, Spare NM, Silberstein SD.
    Headache; 2019 Jul 09; 59 Suppl 2():20-32. PubMed ID: 31291020
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.